CRYSTALLINE AND AMORPHOUS 4-CYANO-Namp;LCUB;(2R)-2-4-(2,3,DIHYDRO-BENZO1,4DIOXIN-5-YL)-PIPERAZIN-1-YL-PROPYLamp;RCUB;N-PYRIDIN-2-PYRIDIN-2-YL-BENZAMIDE HYDROCHLORIDE

摘要

The present invention is directed to crystal and amorphous forms of the 5-HT1A receptor antagonist 4-cyano-N-{(2R)-2-[4-(2,3-dihydro-benzo[ 1,4]dioxin-5-yl)-piperazin-1 -yl]-propyl}-N-pyridin-2-yl-benzamide hydrochloride, as well as compositions thereof and methods of using the same. (I)